窪田製薬ホールディングス
4596
東証グロース
医薬品
窪田製薬ホールディングスの決算推移
損益計算書
(単位:百万円)
2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|
売上高 | 870 | N/A | N/A | N/A | 37 | N/A | 8 | 39 |
売上原価 | N/A | N/A | N/A | N/A | N/A | N/A | 5 | 11 |
売上総利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
販管費 | N/A | N/A | N/A | 532 | 606 | 603 | 601 | 632 |
営業利益 | N/A | N/A | N/A | -3,289 | -2,485 | -2,585 | -2,039 | -1,505 |
営業外収益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
営業外費用 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
経常利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別利益 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
特別損失 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | -3,953 | -3,445 | -3,047 | -3,066 | -2,438 | -2,617 | -2,016 | -1,490 |
貸借対照表
(単位:百万円)
2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|
資産 | 17,168 | 13,396 | 11,290 | 8,740 | 6,691 | 4,832 | 4,419 | 3,016 |
流動資産 | N/A | N/A | N/A | 8,177 | 6,417 | 4,625 | 4,181 | 2,869 |
現金及び預金 | 1,042 | 1,169 | 2,584 | 4,192 | 2,533 | 3,977 | 4,048 | 2,767 |
売上債権 | N/A | N/A | N/A | N/A | N/A | N/A | 3 | 1 |
棚卸資産 | N/A | N/A | N/A | N/A | N/A | N/A | 7 | 36 |
固定資産 | N/A | N/A | N/A | 563 | 274 | 207 | 237 | 147 |
負債 | N/A | N/A | N/A | 663 | 698 | 679 | 470 | 370 |
流動負債 | N/A | N/A | N/A | 505 | 506 | 542 | 360 | 282 |
仕入債務 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
固定負債 | N/A | N/A | N/A | 158 | 192 | 137 | 109 | 87 |
純資産 | 16,520 | N/A | N/A | 8,077 | 5,993 | 4,152 | 3,949 | 2,646 |
利益剰余金 | N/A | N/A | N/A | -17,111 | -19,549 | -22,165 | -24,181 | -25,671 |
自己株式 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |